Albireo Ready To Seek Second Bylvay Indication In Alagille Syndrome

Phase III Success Will Support Filing

 
• By Joseph Haas
  
LFTs
Albireo hopes to add a second rare liver disease to Bylvay's label • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business